IMFINZI® will serve as a first-line treatment for locally advanced or metastatic cholangiocarcinoma in combination with chemotherapy (Gem/Cis).

Steve Holmes

“Empower the Patient – Increase Survival. Therefore, the more empowered patients and caregivers there are, the more survivors we’ll see.” SteveH

AstraZeneca’s Imfinzi breaks decade Long Drought in Cholangiocarcinoma

Hi all, I’ve been a bit pushed for time recently, so I’ve circled back to provide a summary of the recent Imfinzi/PBS news.

Introduction: A New Ray of Hope

Introduction

Hi all, I’ve been a bit pushed for time recently, so I’ve circled back to provide a summary of the recent Imfinzi/PBS news.

A New Ray of Hope

Starting from December 1, 2023, Australians with advanced biliary tract cancer (BTC) can now access IMFINZI® (durvalumab) through the Pharmaceutical Benefits Scheme (PBS). This development is particularly meaningful for me, as someone who has personally benefited from such initiatives.

The Power of Empowerment

I know firsthand the importance of taking full responsibility for your diagnosis, and my approach is clear:

Empower the patient and caregiver – increase survival.

Therefore, the more empowered patients and caregivers there are, the more survivors we’ll see.

IMFINZI®: A Beacon of Hope

IMFINZI® will serve as a first-line treatment for locally advanced or metastatic cholangiocarcinoma in combination with chemotherapy (Gem/Cis). This news brings new tangible hope to our patient community, and I’m optimistic that AstraZeneca’s approach to intervention therapy will open further opportunities for patients sooner than later.

A Decade in the Making

To be clear, this is the first significant advantage we have seen in a decade.

Our Mission: Simplify and Empower

Through my work with Cholangiocarcinoma Foundation Australia, I’m working to ensure that today’s medical science reaches today’s patient toolkit in a manner that we can understand and apply effectively.

The Power of Simplification

To achieve this, I continue to simplify Cancer and Genomic Sciences, to ensure the effective utilisation of today’s medical breakthroughs, leading to improved outcomes for today’s patients and their families. This is a basic yet logical approach that improves the quality of advocacy and how patients and caregivers can better equip and empower their capabilities to respond and survive a seemingly impossible obstacle.

Conclusion

As we move forward, let’s remember that empowerment through simplification is key to our mission. Together, we can navigate the complex world of cholangiocarcinoma and bring hope to our community.

Stay informed, stay empowered.

Hope this has been helpful
Steve

Follow, Contribute, or Start a Challenge

Cholangio Challengers

Join Cholangio Challengers and turn today’s science into today’s survival

“Step up with Cholangio Challengers and be the catalyst in transforming today’s evidence-based medical science into real-world survival victories! Whether you run marathons, bake cupcakes, cycle, swim, knit, or host online garage sales – your passion and support become a formidable slingshot to conquer the Cholangio Goliath. Every challenge you embrace is powerfully simple yet incredibly impactful, helping us dramatically amplify survival rates. Your involvement is more than just support; it’s a life-changing force. Join us and make a tangible difference today!”